Nazzal O, Suárez E, Olfos P, Campodónico I
Departamento de Obstetricia y Ginecología, Hospital Clínico San Borja-Arriarán, Universidad de Chile.
Rev Chil Obstet Ginecol. 1993;58(4):281-91; discussion 291-2.
The results in the treatment of ovarian cancer in our center are analyzed from 1976 until 1989. Seventy nine patients have been treated. Patients were staged as by FIGO guidelines. Thirty three patients were staged as stage I, 9 as stage II, 26 as stage III and as stage IV. Median follow-up is 72 months with a minimum of 12. The actuarial survival was 93.8% for stage I, 36.3% stage II, 6.9% stage III 6.9% stage III and 9% in stage IV. The analysis of the prognostic factors was made by the Cox model. The clinical stage was the principal prognostic factor. No prognostic factors were found in stage I, II and IV but in stage III, complete surgery, well differentiated tumors and the possibility of rescue were of good prognosis.
